PDUFA Date

A PDUFA date (Prescription Drug User Fee Act date) is the FDA-mandated deadline by which the agency must complete its review of a pharmaceutical or biologic drug application. Under PDUFA, drug manufacturers pay user fees to the FDA in exchange for defined, predictable review timelines. The PDUFA date is set when the FDA accepts a New Drug Application (NDA) or Biologics License Application (BLA) for review — typically 10–12 months after filing.

For biotech and pharmaceutical investors and traders, PDUFA dates are among the most important dates on the catalyst calendar. They represent scheduled binary events: the FDA will either approve the drug, issue a Complete Response Letter (rejection requiring additional work before resubmission), or grant a 3-month extension to continue reviewing. Each outcome has dramatically different stock price implications.

How PDUFA Dates Are Tracked

PDUFA dates are disclosed by pharmaceutical companies in SEC filings (8-K forms, 10-K annual reports, 10-Q quarterly reports) and press releases when the FDA accepts their application. Financial data providers and investor relations databases compile these into searchable PDUFA calendars. Active biotech traders maintain watchlists of upcoming PDUFA dates across dozens of companies simultaneously, monitoring pre-PDUFA signals (options flow, dark pool activity, short interest changes) in the weeks leading up to the date.

Pre-PDUFA Trading Considerations

Options pricing ahead of a PDUFA date reflects the market's expectation of a large binary move. The ATM straddle price (cost of buying both a call and put at the current stock price) represents the "priced in" expected move. Traders who buy stocks or calls before a PDUFA date must move more than the priced-in amount to generate a profit — the options market has already embedded the expected catalyst move into prices. The most actionable PDUFA setups are those where the market has underpriced the probability of approval (unusual call activity building despite low consensus approval expectations) or where a short squeeze amplifier is present. TradeAI News tracks active PDUFA dates and fires immediate alerts when FDA decisions are announced — including early announcements that come before the scheduled PDUFA date.